AVEO Oncology (AVEO)

P/S ratio on March 24, 2023 (TTM) : 5.53

According to AVEO Oncology 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 18.1. At the end of 2022 the company had a P/S ratio of 3.02.

P/S ratio history for AVEO Oncology from 2010 to 2022

PS ratio at the end of each year

Year	P/S ratio	Change
2022	3.02	-20.76%
2021	3.81	-86.2%
2020	27.6	692.08%
2019	3.49	-90.68%
2018	37.4	-14.1%
2017	43.6	167.41%
2016	16.3	322.7%
2015	3.85	58.97%
2014	2.42	-96.69%
2013	73.3	301.26%
2012	18.3	305.41%
2011	4.51	-61.31%
2010	11.6

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Biogen BIIB	2.26	-59.12%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	5.67	2.56%	🇺🇸 USA
Merrimack Pharmaceuticals MACK	N/A	N/A	🇺🇸 USA
Bristol-Myers Squibb BMY	2.47	-55.33%	🇺🇸 USA
Eli Lilly LLY	17.5	216.74%	🇺🇸 USA
Amgen AMGN	4.37	-20.96%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for AVEO Oncology (AVEO)

P/S ratio on March 24, 2023 (TTM) : 5.53